Abstract
The origin and/or the evolution of brain diseases of high morbidity and mortality such as cerebrovascular diseases, Alzheimers Dementia or Parkinsons disease have been linked to oxidative stress. Epidemiological or clinical descriptive studies have shown that diets with predominant vegetarian composition or popular beverages like green tea or red wine have beneficial effects on general pathological markers of oxidative stress. The flavonoids, ubiquitous polyphenols in plants and vegetables, have been identified as mainly by responsible for these actions. In apparent agreement with these data, numerous in vitro and in vivo studies have demonstrated a neuroprotective capacity of flavonoids against oxidative or excitotoxic aggressions. Oral flavonoids undergo several metabolic steps and circulate in the blood mainly as metabolites. These metabolites by themselves or after cleavage into non-metabolised flavonoids in the brain would be the active molecules. The intracellular targets of flavonoids are multiple, from chelation of iron to homeostasis of calcium as well as scavenging of free radicals and involvement through kinase modulation, with key intracellular signalling cascades. As key regulators of cell reactivity against oxidative aggressions, the flavonoid molecule can become an ideal template for compounds therapeutically active in stroke, dementia or aging.
Keywords: flavonoids, brain, ischemia, antioxidants, oxidative stress
Current Neuropharmacology
Title: Flavonoids and the Brain: Evidences and Putative Mechanisms for a Protective Capacity
Volume: 3 Issue: 3
Author(s): F. Dajas, F. Arredondo, C. Echeverry, M. Ferreira, A. Morquio and F. Rivera
Affiliation:
Keywords: flavonoids, brain, ischemia, antioxidants, oxidative stress
Abstract: The origin and/or the evolution of brain diseases of high morbidity and mortality such as cerebrovascular diseases, Alzheimers Dementia or Parkinsons disease have been linked to oxidative stress. Epidemiological or clinical descriptive studies have shown that diets with predominant vegetarian composition or popular beverages like green tea or red wine have beneficial effects on general pathological markers of oxidative stress. The flavonoids, ubiquitous polyphenols in plants and vegetables, have been identified as mainly by responsible for these actions. In apparent agreement with these data, numerous in vitro and in vivo studies have demonstrated a neuroprotective capacity of flavonoids against oxidative or excitotoxic aggressions. Oral flavonoids undergo several metabolic steps and circulate in the blood mainly as metabolites. These metabolites by themselves or after cleavage into non-metabolised flavonoids in the brain would be the active molecules. The intracellular targets of flavonoids are multiple, from chelation of iron to homeostasis of calcium as well as scavenging of free radicals and involvement through kinase modulation, with key intracellular signalling cascades. As key regulators of cell reactivity against oxidative aggressions, the flavonoid molecule can become an ideal template for compounds therapeutically active in stroke, dementia or aging.
Export Options
About this article
Cite this article as:
Dajas F., Arredondo F., Echeverry C., Ferreira M., Morquio A. and Rivera F., Flavonoids and the Brain: Evidences and Putative Mechanisms for a Protective Capacity, Current Neuropharmacology 2005; 3 (3) . https://dx.doi.org/10.2174/1570159054368303
DOI https://dx.doi.org/10.2174/1570159054368303 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome
Current Alzheimer Research Colloidal Polymeric Nanoparticles and Brain Drug Delivery
Current Drug Delivery Transglutaminase-Catalyzed Crosslinking in Neurological Disease: From Experimental Evidence to Therapeutic Inhibition
CNS & Neurological Disorders - Drug Targets Elevated Aβ42 in Aged, Non-demented Individuals with Cerebral Atherosclerosis
Current Alzheimer Research Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Vascular Patency: A Biomarker and Clinical Target Quantified with High Resolution MRI and Novel Cellular Pathways
Current Neurovascular Research Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis
Current Medicinal Chemistry Machine Learning and Social Network Analysis Applied to Alzheimer's Disease Biomarkers
Current Topics in Medicinal Chemistry Myokines in Myogenesis and Health
Recent Patents on Biotechnology GLP-1RA and SGLT2i: Cardiovascular Impact on Diabetic Patients
Current Hypertension Reviews The Pharmacological Management of Delirium in Critical Illness
Current Drug Therapy Preventive Effect of Soybean on Brain Aging and Amyloid-β Accumulation: Comprehensive Analysis of Brain Gene Expression
Recent Patents on Food, Nutrition & Agriculture TRPC Channels and their Implications for Neurological Diseases
CNS & Neurological Disorders - Drug Targets The Usefulness of Amyloid Imaging in Predicting the Clinical Outcome After Two Years in Subjects with Mild Cognitive Impairment
Current Alzheimer Research Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeo - static Signaling
Current Psychopharmacology The Honolulu-Asia Aging Study: Epidemiologic and Neuropathologic Research on Cognitive Impairment
Current Alzheimer Research Editorial [The Multifactorial Nature of Alzheimers Disease and Related Therapeutic Strategies (Executive Editors: Maria do Carmo Carreiras and Jose Marco-Contelles)]
Current Pharmaceutical Design Primary and Secondary Stroke Prevention with Antiplatelet Drugs
Current Pharmaceutical Design Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer’s Disease
Current Alzheimer Research